Endpoints News ١٤ فبراير ٢٠٢٦ Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
FierceBiotech ١٣ فبراير ٢٠٢٦ With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
FierceBiotech ١٢ فبراير ٢٠٢٦ UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
Endpoints News ١١ فبراير ٢٠٢٦ Prasad overruled vaccine review team, office director on Moderna flu shot
FierceBiotech ١١ فبراير ٢٠٢٦ Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Endpoints News ١٠ فبراير ٢٠٢٦ Moderna accuses FDA of shifting standard as agency refuses flu shot review
FierceBiotech ٣٠ يناير ٢٠٢٦ Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
FierceBiotech ٢٣ يناير ٢٠٢٦ Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
FierceBiotech ٢٠ يناير ٢٠٢٦ Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years